Introduction {#Sec1}
============

The diagnosis of periprosthetic joint infection (PJI) remains a challenge for clinicians due to the lack of a gold standard method \[[@CR1]\]. Precise diagnosis is difficult, and the key to the successful management of PJI. Preoperative diagnoses are a preliminary screening tool of suspected infection cases in the early stages and provide valuable information on further diagnostic procedures or help to rule out infection. In recent years, systemic inflammatory markers and synovial fluid biomarkers have been a popular research topic \[[@CR2], [@CR3]\]. Compared with blood tests, synovial fluid tests depend more on the personal surgical experience of the physician. Accordingly, a number of test results were decided by the examiner's subjective judgement, although the joint aspiration procedure can affect the final result \[[@CR4]--[@CR7]\]. Therefore, blood tests may be convenient, more stable and cost-effective, and easier to popularize for diagnosing PJI. Serum erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) are the most commonly used and first-line blood examinations in the diagnosis of PJI. Both tests are included in the guidelines of the American Academy of Orthopedic Surgeons (AAOS) and Musculoskeletal Infection Society (MSIS) \[[@CR8]\]. However, CRP, ESR, and the combination of both have a high sensitivity and low specificity for the diagnosis of PJI \[[@CR9]\]. Moreover, the levels of ESR and CRP were reported to be normal in low-virulence organisms \[[@CR10]\]. New complementary or alternative serum biomarkers to CRP or ESR are required to further improve the diagnostic accuracy. D-dimer is routinely measured for excluding suspected venous thromboembolic disease in orthopaedics \[[@CR11], [@CR12]\]. Serum D-dimer is a promising biomarker in the diagnosis of PJI, with higher sensitivity and specificity than ESR or CRP \[[@CR13]\]. The newly defined criteria of the MSIS also included the elevated serum D-dimer, with more than 850 ng/mL as a minor indicator \[[@CR14]\]. Nevertheless, recent studies have been controversial regarding the diagnostic value of D-dimer \[[@CR15], [@CR16]\]. Although both serum and plasma D-dimer were used for diagnosing PJI \[[@CR17], [@CR18]\], their diagnostic value has not yet been assessed. The purpose of the present meta-analysis was to determine the accuracy of serum and/or plasma D-dimer in diagnosing PJI.

Methods {#Sec2}
=======

Search strategy {#Sec3}
---------------

We searched electronic databases, including PubMed, Embase, and Web of Science for articles that were published on the diagnostic use of D-dimer in detecting PJI. The first article was published in 2017. Therefore, the search time was set between 2017 and 2019. The search strategy is presented in Table [1](#Tab1){ref-type="table"}. In addition, the reference lists of the included studies and relevant literature on D-dimer were also searched manually to identify potential studies until no additional articles could be found. Duplicated articles were removed in Endnote version X9 reference manager software (Thomson Reuters, New York City, NY). Table 1Search strategy and results between 2017 and 2019NumberMedical subject headings (MeSH) or text keywordsWeb of Science/PubMed/EMbase (items found)\#1Arthroplasty or joint prosthesis or joint replacement or periprosthetic joint or prosthetic joint14,141/16,517/18,358\#2Infection or infectious or infected202,428/206,267/281,637\#3D-dimer or serum D-dimer or plasma D-dimer or fibrin degradation products1519/1764/3454\#4\#1 AND \#2 AND \#319/20/18

Eligibility criteria {#Sec4}
--------------------

Articles were selected according to the following inclusion criteria: (1) the diagnosis of PJI was confirmed by the International Consensus Meeting (ICM), Infectious Diseases Society of America (IDSA), MSIS, or European Bone and Joint Infection Society (EBJIS) criteria or any other definition, including clinical signs of infection, presence of sinus tract or purulence around the prosthesis, histopathological examination of periprosthetic tissue indicating acute inflammation or positive culture result from synovial fluid, and periprosthetic tissue samples or sonication fluid \[[@CR1], [@CR8], [@CR19]--[@CR21]\]; (2) the number of true-positive (TP), true-negative (TN), false-positive (FP), and false-negative (FN) values were clearly described or could be calculated by their corresponding sensitivity and specificity in each study; and (3) publications written in English.

Quality assessment {#Sec5}
------------------

Search results were screened independently in accordance with the inclusion criteria by two investigators. All included studies were assessed according to the QUADAS-2 guidelines \[[@CR22]\]. A third author adjudicated any disagreement in the evaluation of the studies.

Data extraction {#Sec6}
---------------

Data extraction was completed independently by two investigators and subsequently rechecked by other investigators involved in the study. The following information was abstracted from the articles: first author, year of publication, country, enrolment period, study design, number of total cases and infected cases, type of prosthetic joint, acquisition time, cut-off, diagnostic criteria, potentially influencing elements, the use of antibiotics, and the sensitivity and specificity of the D-dimer test.

Statistical analysis {#Sec7}
--------------------

For the analysis of the diagnostic value of the D-dimer test, all statistical analyses were performed using Meta-Disc software (version 1.4, Unit of Clinical Biostatistics team, Madrid, Spain) \[[@CR23]\]. The pooled sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), and diagnostic odds ratio (DOR) were calculated by a bivariate random-effects regression model. The *I*^2^ statistic was used to assess the heterogeneity of the included studies, with a range of values from 0 to 100%. Significant heterogeneity exists when the *I*^2^ value is greater than 50%, and a value of 0% indicates no observed heterogeneity. If heterogeneity existed, subgroup analysis and meta-regression were performed to explain the potential source of heterogeneity, including the study design, type of blood sample, and cut-offs.

Results {#Sec8}
=======

Literature search results {#Sec9}
-------------------------

From the selected databases, a total of 57 articles were obtained. Thirty-one articles were excluded due to multiple indexing in different databases. After reviewing the abstracts and full articles, seven articles met the inclusion criteria \[[@CR13], [@CR15]--[@CR18], [@CR24], [@CR25]\]. A flow diagram of the selection process is shown in Fig. [1](#Fig1){ref-type="fig"}. Fig. 1Flow diagram of the selection process for eligible studies

Characteristics of the eligible studies and quality of the included studies {#Sec10}
---------------------------------------------------------------------------

A total of 1285 hip and knee cases were included in the meta-analysis. The first study was published in 2017 in the USA, and the remaining six papers originated from China in 2019. Among these seven studies, three were conducted retrospectively, whereas the remaining four were prospective studies. Only two studies provided details on antibiotic use. Characteristics of the included studies are summarized in Tables [2](#Tab2){ref-type="table"} and [3](#Tab3){ref-type="table"}. The QUADAS-2 assessments for each study are shown in Table [4](#Tab4){ref-type="table"}. Results indicated that the included studies were of good quality. Table 2Characteristics of the included studies for meta-analysisStudyCountryEnrolment periodTotal casesInfected casesStudy designLocationCut-off (ng/mL)SenSpeStandardReceived antibioticsExclusion criteriaInclusion criteriaAcquisition time\[[@CR13]\]USAFrom April 2015 to August 201619557Prospective studyHip, knee85089.47%92.75%ICM criteria (2014)Yes1, 9, 10, 11, 132, 15The day of surgery\[[@CR17]\]ChinaFrom October 2016 to October 20173015Prospective studyHip, knee85066.67%60.00%MSIS criteria (2011)NA3, 4, 12, 15Before surgery\[[@CR15]\]ChinaFrom June 2016 to December 201810131Retrospective studyHip, knee85071%80%ICM criteria (2014)NA1, 2, 4, 9, 10, 11, 13, 15Before surgery\[[@CR25]\]ChinaFrom January 2016 to December 201743976Retrospective study (multicentre)Hip, knee125064.5%65%ICM criteria (2014)NA2, 4, 5, 6, 15The day of admission\[[@CR18]\]ChinaFrom April 2017 to August 20188026Prospective studyHip, knee75680.77%79.63%MSIS criteria (2011)NA1, 5, 9, 11, 15The day before surgery\[[@CR24]\]ChinaFrom January 2013 to December 2018318129Retrospective StudyHip, knee102068.29%50.70%ICM criteria (2014)Yes8, 9, 142, 4, 5, 7, 15The day of admission\[[@CR16]\]ChinaFrom January 2015 to December 201812255Prospective studyHip, knee117092.73%74.63%ICM criteria (2014)NA3, 4, 5, 7, 11, 13, 15The day before surgery*Sen* sensitivity, *Spe* specificity, *ICM* International Consensus Meeting, *MSIS* Musculoskeletal Infection Society, *NA* Not availableTable 3Potential influencing elements on D-dimer resultsNumberInclusion or exclusion criteria**1**Hematoma**2**Systemic inflammatory diseases, such as systemic lupus erythematosus, psoriasis, polymyalgia rheumatica, sarcoidosis, inflammatory bowel disease, gout, hepatitis B and C, lymphocytic leukaemia, myelodysplastic syndrome, and multiple myeloma**3**Obesity (body mass index \[BMI\] \> 30 kg/m2), heavy smoking**4**Malignancies**5**Venous thrombosis**6**Cardiovascular and cerebrovascular diseases**7**Infection in other regions of the body**8**Reimplantation surgery**9**History of recent trauma or dislocation (within 2 weeks)**10**Any type of skin ulcer**11**Visible ecchymosis or a history of hypercoagulation disorder**12**Viral infections**13**Prosthetic heart valve**14**Periprosthetic fracture or joint dislocation**15**Inflammatory arthritisTable 4QUADAS-2 evaluation resultsStudyRisk of biasApplicability concernsPatient selectionIndex testReference standardFlow and timingPatient selectionIndex testReference standardStudy 1☺☺?☺☺☹?Study 2☺☺☺☺☺☺☺Study 3☺☺☺☺☺☺☺Study 4☺?☺☺☺☺☺Study 5☺?☺☺☺☺☺Study 6☺?☺☺☺☹☺Study 7☺?☺☺☺☺☺☺, low risk; ☹, high risk; ?, unclear risk

Diagnostic value of the D-dimer test for PJI {#Sec11}
--------------------------------------------

There was significant heterogeneity in the sensitivity (*I*^2^ = 78.4%), specificity (*I*^2^ = 93%), PLR (*I*^2^ = 92.1%), NLR (*I*^2^ = 83.9%), and DOR (*I*^2^ = 90.7%). Therefore, a random-effects model was used. The pooled sensitivity, specificity, PLR, NLR, and DOR estimates for the detection of PJI using the D-dimer test were 0.75 (95% CI 0.70--0.79), 0.69 (95% CI 0.66--0.72), 3.01 (95% CI 1.84--4.93), 0.32 (95% CI 0.19--0.53), and 10.20 (95% CI 3.63--28.64), respectively (Figs. [2](#Fig2){ref-type="fig"}, [3](#Fig3){ref-type="fig"}, [4](#Fig4){ref-type="fig"}, [5](#Fig5){ref-type="fig"}, and [6](#Fig6){ref-type="fig"}). The summary receiver operating characteristic (SROC) plot showed the sensitivity and specificity as well as the 95% confidence intervals and prediction regions, with an area under the curve (AUC) of 0.8288 (standard error, 0.0525; Fig. [7](#Fig7){ref-type="fig"}). The subgroup analysis of serum and plasma D-dimer is shown in Table [5](#Tab5){ref-type="table"}. Fig. 2Forest plots of sensitivity of D-dimer for PJI diagnosisFig. 3Forest plots of specificity of D-dimer for PJI diagnosisFig. 4Forest plots of positive likelihood ratio of D-dimer for PJI diagnosisFig. 5Forest plots of negative likelihood ratio of D-dimer for PJI diagnosisFig. 6Forest plots of diagnostic odds ratio of D-dimer for PJI diagnosisFig. 7Summary of SROC of D-dimer for PJI diagnosisTable 5Subgroup analysis resultsSubgroup analysesNo. of papersNo. of patientsSenSpePLRNLRDORSROC (SE)Overall studies712850.75 (0.70--0.79)0.69 (0.66--0.72)3.01 (1.84--4.93)0.32 (0.19--0.53)10.2 (3.63--28.64)0.8288 (0.0525)Type of blood sample Plasma37870.67 (0.60--0.73)0.60 (0.56--0.64)1.59 (1.28--1.99)0.59 (0.48--0.72)2.69 (1.92--3.77)0.6599 (0.0261) Serum44980.86 (0.80--0.91)0.84 (0.80--0.88)4.91 (2.85--8.48)0.19 (0.09--0.37)28.25 (9.60--83.15)0.9096 (0.0332)*Sen* sensitivity, *Spe* specificity, *PLR* positive likelihood ratio, *NLR* negative likelihood ratio, *DOR* diagnostic odds ratio, *SROC* summary receiver operating characteristic, *SE* standard error

Discussion {#Sec12}
==========

Early diagnosis is the first and most crucial step in the management of PJI. Preoperative testing is at the forefront in assessing an infection, providing valuable information for primary differential diagnosis and further clinical decisions. The measurement of CRP or ESR is a preoperative examination that is a rapid, convenient, simple, and widely used diagnostic method for PJI. However, their diagnostic value is limited due to its low diagnostic accuracy, with levels especially susceptible to fluctuations in patients with dual taper modular stems, slow-growing organisms, and antibiotic treatment \[[@CR26]--[@CR28]\]. Unfortunately, at present, only CRP and ESR appear to be more suitable for the diagnosis of PJI than other serological tests \[[@CR29]\]. Shahi et al. \[[@CR13]\] first used serum D-dimer (850 ng/mL) for the diagnosis of PJI, showing a higher sensitivity and specificity than ESR and CRP (sensitivity: 89% *vs.* 73% and 79%; specificity: 93% *vs.* 78% and 80%, respectively), even when evaluating the combined sensitivity and specificity of ESR and CRP. In an earlier animal study conducted by Ribera et al. \[[@CR30]\], the synovial D-dimer concentration was found to be significantly increased in foals with septic joints (*p* \< 0.001). In a prospective study measuring the ESR, CRP, and D-dimer levels before and after primary total hip or knee arthroplasty, the most significant changes in D-dimer levels were observed during the early postoperative period. Levels were sharply increased and peaked on the first day after joint replacement surgery, decreasing to baseline levels on the following day. The author speculated the combination of D-dimer with ESR and CRP might be effective in the early detection of PJI \[[@CR31]\]. In the last two years, serum D-dimer was recommended as a promising biomarker in diagnosing PJI and was included in the 2018 ICM criteria for PJI \[[@CR32]\].

In the present meta-analysis, the pooled sensitivity and specificity of serum and plasma D-dimer were 0.75 (95% CI 0.70--0.79) and 0.69 (95% CI 0.66--0.72), respectively. The overall diagnostic value of D-dimer had an acceptable sensitivity, whereas the specificity was low. In the subgroup analysis, we found the serum D-dimer to have a better sensitivity and specificity than plasma D-dimer (0.86 and 0.84 vs. 0.67 and 0.60, respectively).

In a prospective study on revision hip and knee arthroplasty, the serum D-dimer had 92.73% sensitivity and 74.63% specificity with a threshold value of 1170 ng/mL \[[@CR16]\]. The diagnostic sensitivity and specificity of serum D-dimer were higher than those of CRP (81% and 66%, respectively) and ESR (64% and 70%, respectively), in addition to their combination (89% and 57%, respectively). These results are similar to those of the previously published results of Shahi et al. \[[@CR13]\]. However, both studies used different threshold values and differed in the inclusion of systemic inflammatory diseases. In addition, Qin et al. \[[@CR16]\] also demonstrated that the combination of serum D-dimer and CRP could achieve the highest sensitivity compared with each alone. However, the sensitivity and specificity of serum D-dimer, CRP, and ESR were reported not to significantly differ when using a serum CRP level of 10 mg/L (68% and 93%, respectively), ESR level of 30 mm/h (74% and 87%, respectively), and D-dimer level of 850 ng/mL (71% and 80%, respectively) as the threshold \[[@CR15]\]. In the study performed by Xiong et al. \[[@CR18]\], the diagnostic value of serum D-dimer, CRP, and ESR were observed to be equivalent, with results demonstrating the AUCs to be 0.890, 0.831, and 0.838, respectively \[[@CR18]\]. From the studies described above, serum D-dimer had a better or equal diagnostic accuracy to CRP and ESR.

In recent years, the diagnostic accuracy of plasma D-dimer for the diagnosis of PJI was also tested. A retrospective cohort study measured the CRP, ESR, interleukin-6 (IL-6), plasma fibrin degradation product (FDP), and D-dimer in diagnosing PJI \[[@CR24]\]. The potentially influencing elements included inflammatory disease and antibiotic use. Compared with traditional inflammatory markers, plasma FDP and D-dimer had a lower sensitivity and specificity than CRP, ESR, and IL-6. The sensitivity of the combination of D-dimer and one of the inflammatory marker were decreased compared with the sole use of the indicators, as well as plasma FDP. However, the sensitivity of the combination of D-dimer or one of the inflammatory markers were elevated compared with the sole use of the indicators, and plasma FDP also had similar results. The authors concluded that the diagnostic value of plasma FDP and D-dimer was limited compared to traditional inflammatory markers \[[@CR24]\]. A prospective study reported the sensitivity of plasma D-dimer to be between that of CRP and ESR (66.67% vs. 80.00% and 33.33%, respectively), while its specificity was lowest among all three markers (60.00%) \[[@CR17]\]. Li et al. \[[@CR25]\] showed the diagnostic value of plasma D-dimer to be potentially limited, and the AUC of plasma D-dimer to be inferior to that of plasma fibrinogen, ESR, and CRP (0.657 vs. 0.852, 0.810, and 0.808, respectively). D-dimer only exhibited better performance than that of leukocytes (0.590). Compared with the D-dimer, the diagnostic level of plasma fibrinogen was closer to that of the traditional inflammatory markers ESR and CRP. Moreover, the author also analysed the diagnostic accuracy of D-dimer and fibrinogen with coagulation-related comorbidities (malignancy, autoimmune disease, cardiovascular disease, and cerebrovascular disease). The diagnostic accuracy of D-dimer ranged from 50 to 57.7%, whereas the diagnostic accuracy of plasma fibrinogen ranged from 52.4 to 92.3%. Plasma fibrinogen had better diagnostic accuracy than D-dimer, especially in patients with malignancy. Xu and colleagues assessed the diagnostic value of plasma D-dimer and fibrinogen before reimplantation in two-stage exchange arthroplasty for periprosthetic hip infection \[[@CR33]\]. Plasma D-dimer was observed to have a lower sensitivity and specificity than fibrinogen (83.3% and 41.9% vs. 87.5% and 62.8%, respectively); however, it was inferior to fibrinogen. Nevertheless, compared with previous studies on serum CRP and ESR before reimplantation, plasma D-dimer appears to be a better diagnostic indicator \[[@CR34], [@CR35]\]. The first serum D-dimer study performed by Shahi and co-workers also found that the two cases of failed second stage replacement caused by reinfection had increased D-dimer levels before reimplantation surgery, while serum CRP and ESR levels were normal \[[@CR13]\].

Compared with previous meta-analyses of PJI diagnoses \[[@CR36], [@CR37]\], all included papers in this study used similar gold standards. Yet there were several limitations in the current meta-analysis. First, of the seven included studies, six were from China. Whether differences exist in D-dimer values in the diagnosis of PJI in different countries or races is unclear. However, a study performed in the American community-dwelling elderly indicated that black individuals had significantly higher D-dimer levels than white individuals \[[@CR38]\]. Further research on whether D-dimer levels are affected by racial differences in normal or PJI patients is required. Second, among these seven papers, only two studies were found describing details of antibiotic use \[[@CR13], [@CR24]\]. In addition, all of these publications used different exclusion criteria, which might impact the diagnostic results. Third, from the meta-analysis results, serum D-dimer was found to have a better sensitivity and specificity than plasma D-dimer (86% and 84% vs. 67% and 60%, respectively). However, due to the limited data available, only three studies utilized plasma D-dimer in PJI. Therefore, further PJI studies are required to compare the diagnostic value of serum D-dimer and plasma D-dimer in the future.

Conclusion {#Sec13}
==========

The overall meta-analysis results of serum and plasma D-dimer levels showed low sensitivity and specificity. However, based on the present literature and our subgroup analysis results, serum D-dimer has a better diagnostic value than plasma D-dimer for the diagnosis of PJI; further research is required to verify the present findings.
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